Signature Estate & Investment Advisors LLC Raises Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Signature Estate & Investment Advisors LLC increased its stake in Intuitive Surgical by 85.0%, now owning 1,426 shares valued at $775,000.
• Intuitive Surgical's stock price is currently at $446.13, with a market capitalization of $159.93 billion, and analysts predict an average price target of $580.29.
• Insider selling has occurred recently, with EVP Myriam Curet and CEO Gary S. Guthart selling a combined total of 45,224 shares valued over $21 million in the past three months.

Signature Estate & Investment Advisors LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 85.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 1,426 shares of the medical equipment provider's stock after buying an additional 655 shares during the period. Signature Estate & Investment Advisors LLC's holdings in Intuitive Surgical were worth $775,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Norway Savings Bank boosted its position in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider's stock worth $1,420,000 after acquiring an additional 910 shares during the last quarter. IronOak Wealth LLC. acquired a new stake in Intuitive Surgical during the second quarter worth approximately $1,099,000. Trust Co. of Oklahoma acquired a new stake in Intuitive Surgical during the second quarter worth approximately $363,000. Neville Rodie & Shaw Inc. boosted its position in shares of Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider's stock worth $5,666,000 after acquiring an additional 1,110 shares during the last quarter. Finally, Sax Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 218.1% in the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider's stock worth $1,334,000 after acquiring an additional 1,684 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 over the last ninety days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 2.6%

Shares of ISRG stock opened at $446.13 on Monday. The stock has a market cap of $159.93 billion, a price-to-earnings ratio of 62.22, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm's 50 day moving average price is $454.97 and its two-hundred day moving average price is $495.76.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.78 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Wall Street Zen cut shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Saturday. Piper Sandler reissued an "overweight" rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Fourteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $580.29.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.